TheraNovis

AstraTSA kit

A high-performance, versatile Multiplex IHC product

Technical Specifications
AstraTSA kit
Reagents

Overview

AstraTSA kits provide unparalleled sensitivity for low-abundance targets. Our proprietary tyramide signal amplification technology ensures robust, bright signals that stand the test of time, making them perfect for multiplexing applications.

Key Features

  • 10–100× enhanced sensitivity compared to conventional fluorescence
  • Minimized autofluorescence and low background noise
  • Reduced antibody consumption to one-fifth of conventional usage
  • Simultaneous detection of multiple biomarkers (multiplexing)
  • Signal amplification compatible with all immunoassays
  • Compatible with both chromogenic and fluorescently labeled probes

Key Performance Metrics

* Based on internal test results

10–100× Signal Amplification

TSA technology clearly detects low-abundance targets—far exceeding conventional fluorescence

1/5 Antibody Consumption

Drastically reduces costly antibody usage, directly lowering long-term experiment costs

6+ Color Multiplexing

Simultaneous precise analysis of multiple biomarkers on a single slide

Low Background Noise

Minimized autofluorescence design enables clean signal background for accurate quantification

Strategic Advantage

Discover the overwhelming performance advantages over conventional methods and competitors.

METRICSManualExisting
OUR SOLUTIONAstraTSA kit
Signal Sensitivity
Conventional fluorescence (baseline)Single amplification level
10–100× sensitivity enhancement
Antibody Usage
100% standard concentration~50% reduction possible
Reduced to 1/5 of conventional usage
Multiplexing Capacity
Limited to 2–3 colorsUp to 4–5 colors
6+ simultaneous color detection
Autofluorescence Control
Correction requiredPartial suppression
Minimized autofluorescence design
* Verification Data Available Upon Request

Ready to upgrade your lab?

Our team is ready to help you.